Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dexpanthenol, also known as D-panthenol or provitamin B5, is an alcohol analogue of pantothenic acid (vitamin B5). Upon administration, dexpanthenol is enzymatically cleaved and oxidized to pantothenic acid, which serves as an essential precursor for the synthesis of coenzyme A (CoA). Coenzyme A acts as a critical cofactor in numerous enzymatic reactions, including fatty acid synthesis, protein metabolism, and the tricarboxylic acid cycle. In dermatological applications, dexpanthenol acts as a humectant and emollient, improving skin hydration, reducing transepidermal water loss, and promoting fibroblast proliferation and re-epithelialization during wound healing. It is widely utilized in topical formulations for conditions such as atopic dermatitis, radiation dermatitis, and skin recovery following dermatological procedures. Additionally, dexpanthenol is used in ophthalmic gels for corneal re-epithelialization and dry eye syndrome, and has been investigated for its potential neuroprotective and cholinergic effects.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on dexpanthenol.